Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Botulinum Toxin in the Treatment of Acne
IRCT20230529058336N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in acne vulgaris, sponsored by Tehran University of Medical Sciences. Started Jun 2023; status: completed.
02
Drugs
neuronox
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20230529058336N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230529058336N1.